Smith Group Asset Management’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12M Sell
89,979
-223,291
-71% -$2.57M 0.07% 62
2026
Q2
$2.68M Buy
313,270
+49,601
+19% +$350K 0.11% 59
2026
Q1
$1.7M Buy
263,669
+67,393
+34% +$521K 0.09% 70
2025
Q4
$1.6M Buy
196,276
+178,018
+975% +$1.61M 0.09% 72
2025
Q3
$162K Buy
+18,258
New +$115K 0.01% 172

Other funds holding AVAH

Smith Group Asset Management's AVAH Position: Q3 2026 in Review

Smith Group Asset Management reduced its Aveanna Healthcare (AVAH) stake by 71% in Q3 2026, selling an estimated $2.57M and leaving 89,979 shares worth $1.12M. The position accounts for 0.07% of the portfolio, ranked #62.

Smith Group Asset Management first reported a position in AVAH in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.68M in Q2 2026. 36 funds tracked by Wall St. Rank hold AVAH as of Q3 2026.

  • Smith Group Asset Management held 89,979 shares of Aveanna Healthcare worth $1.12M as of Q3 2026.
  • Smith Group Asset Management sold 223,291 Aveanna Healthcare shares in Q3 2026, an estimated $2.57M.
  • Aveanna Healthcare made up 0.07% of Smith Group Asset Management's portfolio in Q3 2026, its #62 holding.
  • Smith Group Asset Management first reported a position in Aveanna Healthcare in Q3 2025 and has held it in 5 quarters since.
  • Smith Group Asset Management's Aveanna Healthcare position peaked at $2.68M in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q3 2026.

Based on Smith Group Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.